interlabservice catalog osnovnoy 3kv 2015

, 115035, . , . , . 20/13, . 2 .: (495) 664 28 84, : (495) 664 28 89 www.interlabservice.ru

-

-

-

II 2015 .

2

, - ................................... 8 - .................................................. 10 ........................ 10 ................................................................................................... 10 / .......................................................................................... 11 ................................................................................... 12 .... 12

NASBA .......................................................................................................... 13 - ......................................................................................................................................................... 13 ............................................... 13 - .......................................................................................................................................................... 14 , ...................................................................................................................................................................... 15 ........................................................ 16 - .................................................................................................................... 17

........................................................................................................................................................................................................... 17 ........................................................................ 17 ...................................................................................................................................................... 18 ...................................................................................................................................................... 18 ........................................................ 19 ...................................................................................................................................................... 20

, .......................... 22 D ...................................................................................................................................................... 22 G ...................................................................................................................................................... 23

........................................................................................................................................................................................ 23 .................................................................................................... 23 ....................................................................................................... 27 Chlamydia trachomatis ............................................................................................................................................ 28 Neisseria gonorrhoeae ............................................................................................................................................. 29 Treponema pallidum ................................................................................................................................................ 30 Trichomonas vaginalis .............................................................................................................................................. 30 Mycoplasma genitalium .......................................................................................................................................... 30 Mycoplasma hominis ................................................................................................................................................ 31 Ureaplasma species ................................................................................................................................................... 32 Ureaplasma ........................................................................................................................... 32 Gardnerella vaginalis ................................................................................................................................................ 33 Candida albicans ........................................................................................................................................................ 33 NASBA-Real-Time ............................................................................................................... 34

............................................................................................................................................................................ 34 ........................................................ 34 ........................................................... 37

- ........................................................................................................................................................................................ 38 .................................................................................................... 38 .................................................................................................................................................... 38 - ............................................................................................................................................ 39

3

Varicella-Zoster virus ................................................................................................................................................ 40 6- ..................................................................................................................... 40 1 2 ................................................................................................................. 40 ........................................................................................................ 41

- ............................................................................................................................................................................. 41 ................................................................................. 42 MDR ....................................................................................................................... 42 TORCH- ................................................................................................................................................ 42 Toxoplasma gondii.................................................................................................................................................... 42 19 ....................................................................................................................................................... 43 .......................................................................................................................................................... 43

................................................................................................................................................................................................................................. 43 . , QIAGEN .......... 43 .................................................................................................... 44 Mycobacterium tuberculosis complex ................................................................................................................. 44 ........................................................ 44

...................................................................................................................................................................... 45 .................................................................................................... 45 / ............................................................................................................................................... 46 A/H1 .................................................................................................................................................. 46 , ....................................................................................................................................... 47 , 5N1 ( ) ..................................................................................................... 47 .................................................................................................................................................... 47 Mycoplasma pneumoniae ....................................................................................................................................... 48 , ........................................................... 48 - .............................................................................................................. 48 ............................................................................................................................................................. 48 Streptococcus species .............................................................................................................................................. 48 Legionella pneumophila .......................................................................................................................................... 49

- ................................................................................................................................................................................................................ 49 .................................................................................................... 49 ........................................................................................................................................................... 50 Listeria monocytogenes ........................................................................................................................................... 50

....................................................................................................................................................................................................... 51 .................................................................................................... 51 ............................................................................................................................................. 52 : 1 2 ........................................................................................................ 52 E.coli .................................................................................................................................................. 52 Helicobacter pylori .................................................................................................................................................... 52 Salmonella species ( ) ........................................................................ 53 Salmonella typhi ........................................................................................................................................................ 53 .................................................... 53

- ................................................................................................................................. 54 .................................................................................................... 54 Bacillus anthracis ....................................................................................................................................................... 54 Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. afzelii, B. garinii) .................................. 54 Brucella species .......................................................................................................................................................... 55

4

Coxiella burnetii ......................................................................................................................................................... 55 Leptospira species ( ) ...................................................................................................... 55 Vibrio cholerae ........................................................................................................................................................... 55 Yersinia pestis ............................................................................................................................................................. 56 ......................................................................................................................................... 56 ............................................................................................................................. 56 ........................................................................................................................................ 56 ..................................................................................................................... 56 - ................................................................. 57

................................................................................................................................................................................ 57 QIAGEN CDx ......................................................................................... 57 QIAGEN Ipsogen (, ) .................. 58 QIAGEN 63 ( ) ........................................................................................... 63 QIAGEN 65 (NGS) ..................................................................................................... 65 QIAGEN (NGS) ...................................................................................................................................................... 66

PYROMARK ............................. 68 () ........................................................................................................................................................................................................................ 71 QIAGEN ............................................................................... 72 ( ) ........................................................................................................................... 72 ..................................................................................................................................................................... 72 ................................................................................................................................................................................ 73 ...................................................................................................................................................................... 73 ................................................................................................................................................................................. 74 - ................................................................................................................ 74

...................................................................................................................................................................................................... 75 ......................................................................................................................................................................................... 76 - .................................................................................................... 76 -................................................................................................................................ 76

......................................................................... 77 ................................................................................................................................................................................... 77 ................................................................................................................................... 77 ..................................................................................................................................... 78 Maxymum Recovery ..................................................................................................................... 79 Axygen () Gene CAS-1200, Tecan EVO, Tecan Genesis, Tecan Freedom, Tecan Miniprep, Cavro workstations,Perkin-Elmer/Packard Multiprobe II HT, Multiprobe II HT EX with Hanging tip. ................................................................................................................ 79 ( ) ......................................... 79

.................................................................................................................................................................................................................................. 80 .................................................................................................................................................................................................................. 80

5

( ) ... 80 Maxymum Recovery ............................................................................................................... 80 ....................................................................................... 80 ...................................................................................................................................................... 81 Corbett Research, Applied Biosystems, BioRad, Eppendorf, Biometra, Stratagene, MWG Biotech (PEQLAB), Beckman . Axygen Scientifiic ..... 81 ..................................................................... 81 ................................................................................................................. 82

....................................................................................................................................................... 82 5-50 ........................................................................................................................ 83 ........................................................................................................................... 84 ............................................................................................................................................................................................................ 84 .................................................................................................................................................................................................................................... 84 ............................................................................................................................................................................................ 85 ............................................................................................................................................................................................................................ 85 ........................................................................................................................................................................................................ 86 ................................................................................................................................................................................................................................... 88 .............................................................................................................................................................................................................. 88 .......................................................................................................................................................................................................................... 88 ........................................................................................................................................................................................ 88 .................................................................................................................................................................................................................................... 89 ............................................................................................................................................................................................ 89 ................................................................................................................................................................................................... 89 , ............................................................................... 90 ........................................................................................................................................................ 90 - ......................................................................................................................................................................... 90 , ..................................................................................................................................................................................................... 90 ....................................................................................................................................................................................................... 91 ............................................................................................................................................................................................................................ 91 ........................................................................................................................................................................................... 91 ............................................................................................................................................................................ 91 QIAGEN ...................................................................................................................................... 91 QIAGEN ......................................................................................................... 91

. 92 Xiril, QIAGEN ..................................................................................................... 92 Xiril .......................................... 92 ...................... 92 QIAsymphony, QIAGEN......................................................................................................................... 92 QIAsymphony SP .................................. 92 QIAcube, QIAGEN ........ 93 QIAcube ........................ 93 QIAcube .......................................................................................... 93 QIAcube .................................. 93 ..................................................... 94 EZ1 Advanced XL, QIAGEN ........ 94 EZ1 Advanced XL ................................................................... 94 QIAgility, QIAGEN .................................................. 94 QIAgility ...................... 94 NucliSens easyMAG ................................................... 95

6

() .......................................................................................................................................................................... 95 QIAGEN ....................................................................................................................... 95 QIAGEN .......................................................................... 95 Axygen ........................................................................................................................ 95 ............................................................................................................... 96

........................................................................................................................................ 96 ................................................................................................................................................................................................................................. 96 ............................................................................................................................. 96 ............................................................................................................................... 96 AxyPet ...................................................................................................................................................... 97 BIOHIT ..................................................................................................................................................... 97 ........................................................................................................................................ 99 ................................................................................................................................................ 99

................................................................................................................................................................... 100 .............................................................................................................................. 100 .............................................................................. 100 .............................................................................................................. 100

.................................................................................................................... 101 ................................................................................................................................................................ 101 PYROMARK, QIAGEN ...................................................................................................................... 101 PyroMark Q24 ................................................................................................................... 101 PyroMark Q24 ..................................................................................................................................................................................... 101

................................................................... 101 ........................................................................................... 101 GEMINI, STRATEC, ............................................................................ 101 Gemini ..... 101

HYDROFLEX ,TECAN, ...................................................................................................................... 102 INFINITE F50,TECAN, ................................................................................................................ 102 SUNRISE, TECAN, .................................................................................................................... 102 ............................................................................................................................................................................. 102 ........................................................................................................................................................................... 103 : ............................................................................................................................................................... 103 , : ............................................................................................................................................................................ 103 . ...................................................................................................................................................................... 103 ............................................................................................................................................................................................ 104 ........................................................................................................................................................................................ 105 ............................................................................................................................................................ 105 ............................................................................................................................................................................. 105 ....................................................................................................................... 108

7

! :

-

-

-- XIRIL.

-

IVD in vitro

RUO

.

- QIAGEN - (NGS). - QIAGEN - (NGS).

.

CFX96 (Bio-Rad, )

CFX:

.

R-V55 Influenza virus /H1-swine-FL R-V55-F(SC) Influenza virus /H1-swine-FL R-V48-S(RG,iQ,Mx) EBV/CMV/HHV6--FL R-V9-100-S(RG,iQ,Mx) EBV-/-FL R-V7-100-S(RG,iQ,Mx) CMV-/-FL B59(RG,iQ,FEP) EHEC-FL B58(RG,iQ,FEP) Cronobacter sakazakii-FL B63(RG,iQ,FEP) Salmonella typhi-FL R-B57(RG,iQ,SC,Dt96) MTC-FL R-B80(RG,iQ,Dt,SC) MTC-diff-FL R-V10-T(RG,iQ,Mx) HHV6---FL

RUO-

8

, -

- ( (), ( - ), , )

() - EPh ElectroPhoretic detection

- ,

**-100-R0,5 100 , 0,5

- , --

-

3 4 :

1. ;

2. () - ;

**-100-R0,2 100 , 0,2

3. ();

4. .

-

- FEP Fluorescence detection with End Point analysis

- ,

T**-100-R0,5-FEP 100 , 0,5

-: ALA- 1/4 (BioSan, (-, -)

-

2 3 :

T**-100-R0,2-FEP 100 , 0,2

1. ;

T**-50-R0,5-FEP 50 , 0,5

2. () - ;

T**-50-R0,2-FEP 50 , 0,2

3. () .

(Real-time PCR) - FRT Fluorescence Real-Time detection

- ,

TR-**- T() - -

-

2 3 :

TR-**- () -

1. ;

TR-**- (RG) Rotor-Gene (Corbett Research, ), Rotor-Gene Q (QIAGEN, )

2. () - ;

TR-**- (iQ) iQ iCycler (Bio-Rad, ) 3. () . TR-**- (SC) SmartCycler (Cepheid, )

TR-**- (Mx) Mx3000P (Strategene, )

TR-**- (CFX) CFX (Bio-Rad, )

()

()-EPh ElectroPhoretic detection

- ,

**-100-R0,5 110 , 0,5 - -, -

**-100-R0,2 110 , 0,2

-

- FEP Fluorescence detection with End Point analysis

- ,

**-100-R0,5-FEP 100 , 0,5 -: ALA- 1/4 (BioSan, ); ( -, )

**-100-R0,2-FEP 100 , 0,2

**-50-R0,5-FEP 50 , 0,5

**-50-R0,2-FEP 50 , 0,2

RUO-

9

(Real-time PCR) - FRT Fluorescence Real-Time detection ( -

)

R-**- (RG) Rotor-Gene ( Corbett Research, ), Rotor-Gene Q (QIAGEN, )

R-**- (iQ) iQ iCycler (Bio-Rad, )

R-**- (SC) SmartCycler (Cepheid, )

R-**- (Mx) Mx3000P (Strategene, )

R-**- (Dt) -96, -322 (-, )

R-**- (Ank) -16/ -32 ( , )

R-**- (CFX) CFX (Bio-Rad, )

- -

PMQ-***-50-F

- Vacuum Prep Workstation (Qiagen, ), PyroMark Q24 PyroMark Q96 MD (Qiagen, )

1. -

2.

3. -

4.

5.

** -

-

: FRT FEP FRT/ FEP / EPh : , -

,

: -

, -

, -, Taq-F ( )

: -

8 - 8

15 - 15

- .

, : 1 , 1 , 3 , 20 .

, : 15 , 15 , 17 , 5 .

-

RUO-

10

-

. .

- -

1533 - , - ( )

8 50 RUO

952

- ()

, . , , 28 , , -

50 IVD

953

, . , , 28 , , -

100 0,5

IVD

956 -

. - , -

30 IVD

987

. - , -

100 0,3

IVD

958 , - -

, . - - ,

100 IVD

959

, . - - ,

8 100 0,5

IVD

981 - ()

9 100 RUO

.

.

-

-

K2-17-100 -

100

- , , - , - - , - . -. - - - (. 1533)

100 IVD

K1-19-100 --

100

100 , -

15

100 RUO

102-22 --

100

- (, , ). . .

100 IVD

103-20 --

100

, , , , , , , ,

100 IVD

RUO-

11

K1-6-50

, - - --

50 , , ,

8 50 IVD

K1-8-100 -- 100

- , -

8 100 RUO

K1-3-100 100 -

8 100 RUO

/ .

.

-

-

104-20 / -

100

/ - (- , , , , - , , , , (), ( (), -, , ..), , - , - , , , , , (, -, ) - , , , , , , , ).

100 IVD

105-20 / -

100

/ - , ( , , , - ( - (), , ..), , - , , , (), (, -, ) , , , -, , , , - , ).

100 IVD

K2-12-50 - 50

/. - --FL . R-V0-R(RG,iQ)

8 50 RUO

K2-14-96 - / - -

100 / - X-Tractor Gene

15

96 IVD

K2-16-200 / -

100-200

/ , - ( 200 -). (. Z5342).

15 100 IVD

RUO-

12

K2-16- 1000

/ -

100-1000

/ , - ( 1000 ). - (. Z5342); 1000 - (. Z5343) - .

15 100 IVD

2496 4 , 0,85

, K. - 1 - Xiril.

8 - RUO

K2-2-100 --

100

- -- () ( ).

8 100 IVD

K2-3-100 --

100

- -- (-) ( , , ).

8 100 IVD

K2-13-100 --

100

- . - - - , , , .

8 100 IVD

K2-18-100 --D 100

- --- ( - )

15

120 RUO

.

.

-

-

K3-4-100 -L

100 -. RT-G-mix-1

120 IVD

K3-4-50 -L

50

-. RT-G-mix-1

8 60 IVD

.

.

-

-

K5-200 - -

200 -

240 IVD

K6-200 - -

--200

- - ( - )

144 IVD

RUO-

13

NASBA -

-. - -. . - . .

-

. .

-

-

TR-V62-Ms(RG,Dt)

- (HCV), B (HBV) - (HIV) - - () - - HCV/HBV/HIV-FL

FRT, 100F, HCV/HBV/ HIV1/HIV2

( ), - (HCV), B (HBV) 1 (HIV-1) 2 (HIV-2) -, - - Xiril. 5- RG, , CFX

15

100 IVD

R-V62 (RG,Dt)

FRT,100F - HCV/ HBV/HIV1/ HIV2

- (HCV), B (HBV) 1 (HIV-1) 2 (HIV-2). / -: - 1000 Xiril NucliSENS easyMAG (bioMerieux, ) 5- RG, , CFX

15

100 IVD

R-V50-4x (RG,iQ,,Dt)

FRT 4-100F - HCV/HBV/HIV1

- (HCV), B (HBV) 1 (HIV-1) / - : -, -, - - 1000 Xiril NucliSENS easyMAG (bioMerieux, ) 4- RG, iQ, Mx, , CFX

15

100 IVD

R-V62-Q(RG,Dt)

- (HCV), B (HBV) - (HIV) - - () -- HCV/HBV/HIV-FL

FRT, 100F - HCV/HBV/HIV1/HIV2

- (HCV), B (HBV) 1 (HIV-1). - - QIAsymphony AS - - . 5- - RG, , CFX

15

100 IVD

RUO-

14

- -

.

.

-

-

TR-V0-G-P1 (RG,iQ,Mx,Dt)

- - (-1) () -- - --FL

FRT, 100F, ,

- (-1), - 100, (1 ) RG, iQ, , Mx, CFX.

15

100 IVD

TR-V0-G-P2 (RG,iQ,Mx,Dt)

- - (-1) () -- - --FL

FRT, 100F, 100 - - , 100 -

- (-1), - 100, (2 ), - (1 ), - (1 ). WHATMAN. RG, iQ, , Mx, CFX.

100/100 IVD

TR-V0-G-S(RG,iQ, Mx,Dt)

- - (-1) () -- - --FL

FRT, 100F,

- (-1) , -- 100, (2 ) - RG, iQ, , Mx, CFX.

15

100 IVD

R-V0-R (RG,iQ,Mx)

--FL

FRT, 50F, -

- . - - NucliSENS easy-MAG - . K2-12-50, . RG, iQ, Mx, CFX.

15

76 RUO

TR-V0-S-M(RG,iQ,,Dt)

- 1 (-1) - - () -- - --FRT

FRT, 48F,

( Rotor-Gene, iQ iCycler, iQ5,Mx3000P, -322,-96), --12) RG, iQ, , Mx ,CFX.

15

48 IVD

TR-V0-P-M(RG,iQ,,Dt)

FRT, 50F,

( Rotor-Gene, iQ iCycler, iQ5,Mx3000P, -322, -96), -) RG, iQ, , Mx ,CFX.

15

50 IVD

RUO-

15

TR-V0-A-M - 1 (-1) - - () -- - --FRT

FRT, 96F,

( Rotor-Gene, iQ iCycler, iQ5, Mx3000P, -322, -96), - -100-1000. - RG, iQ, , Mx ,CFX. - - .

15

100 IVD

R-V0-MC (RG,iQ,Mx,Dt)

FRT, 48F, -

- (- ), ( Rotor-Gene, iQ iCycler, iQ5, Mx3000P, -322, -96) , - , / , QIAsymphony, Xiril, NucliSENS easy- MAG) RG, iQ, , Mx,CFX.

15

80 IVD

TR-V0-MM(Ab)

- 1 (-1) - - () -- - ---FL

FRT, 96F,

. - . R-V0-MM(Ab)-. Abbott m2000rt (Abbott, )

15

96 IVD

R-V0- MM(Ab)-

- ---FL

- , / - - 1 (-1). . TR-V0- MM(Ab)

15

4 -

IVD

, -

.

.

-

-

TR-O2(RG,iQ)

5701 - - (HLA B*5701) () --- - HLA B*5701-FL

FRT,100F,

, -. RG, iQ, Mx, .

15

100 IVD

R-O2(RG,iQ) FRT, 100F,-

5701 (- 5701 - (HLA B*5701) ). RG, iQ, Mx,

15

110 IVD

RUO-

16

-

.

.

-

-

TM-V0-50-F- 1-S

- (-1) - - () - - HIV-Resist-Seq

EPh, 50F

(pro) (rev). Applied Biosystems. Applied Biosystems.

50 IVD

TM-V0-50-F- 2-S

- (-1) - - () - - HIV-Resist-Seq

EPh, 50F

(pro), (rev) (int) . Applied Biosystems. - - Applied Biosystems.

50 IVD

TM-V0-50-F- 3-S

- (-1) - - () - - HIV-Resist-Seq

EPh, 50F

- - V3- (env). Applied Biosystems. Applied Biosystems.

50 IVD

TM-V0-50-F- 4-S

EPh, 50F

(pro), (rev) (int) , - V3- (env). Applied Biosystems. - Applied Biosystems.

50 IVD

TM-V0-50-F-5

- (-1) - - () - - HIV-Resist-Seq

EPh, 50F

(pro) (rev). Applied Biosystems Beckman Coulter. - -- - .

50 IVD

TM-V0-50-F-6

EPh, 50F

(pro), (rev) (int) . Applied Biosystems Beckman Coulter. - - .

50 IVD

RUO-

17

TM-V0-50-F-7

- (-1) - - () - - HIV-Resist-Seq

EPh, 50F

- - V3- (env) Applied Biosystems Beckman Coulter. -- - .

50 IVD

TM-V0-50-F-8

EPh, 50F

(pro), (rev) (int) , - V3- (env). Applied Biosystems Beckman Coulter. - - - .

50 IVD

- -

.

.

-

-

R-F2-Mod (RG,iQ,Mx)

Pneu-mocystis jirovecii (carinii) - - - () -- - Pneumocystis jirovecii (carinii)-FL

FRT, 50F, --

Pneumocystis jirovecii (carinii). RG, iQ, Mx.

15

55 IVD

R-F4-F(RG,iQ)

Cryptococcus neoformans - - () --

Cryptococcus neoformans-FL

FRT, 100F,-

Cryptococcus neoformans ( ). RG, iQ.

15

110 IVD

1 2 . . -. 6 . .Toxo.lasma gondii . TORCH-.Candida albicans .

-

. .

-

-

R-V56 (RG,iQ,Mx,Dt)

- - B (HBV) - D (HDV) () - - HBV/ HDV-FL

FRT, 100F, -

- D(HDV) B (HBV). RG, iQ, Mx, .

15

110 IVD

RUO-

18

-

.

.

-

-

R-V4(RG,iQ)

A (HAV) - - () -- HAV-FL

FRT, 50F, --

- (HAV) - . RG, iQ, Mx.

15

55 IVD

V4-FEP FEP, 50F, -

- (HAV) -

15

55 IVD

-

.

.

-

-

R-V5-Mod (RG,iQ,Mx,Dt)

B (HBV) - () - - HBV-FL

FRT, 100F, -

B (HBV). HBV - (.104-20) - (.105-20). RG, iQ, , Mx ,CFX.

112 IVD

TR-V5-P-M (RG,iQ,,Dt)

- (HBV) - () - - - HBV--FL

FRT, 50F,

B (HBV) - B (HBV) , - -. RG, iQ, , Mx ,CFX.

15

50 IVD

TR-V5-S-MC (RG,iQ,Mx,Dt)

- (HBV) - () - - - HBV--FL

FRT, 48F,

B (HBV) , --12. RG, iQ, , Mx, CFX.

48 IVD

TR-V5-M-MC (RG,iQ,Mx,Dt)

- (HBV) - () - - - HBV--FL

FRT,100F, - -

B (HBV) , - 100-1000. RG, iQ, , Mx, CFX.

15

100 IVD

RUO-

19

R-V5-MC (RG,iQ,,Dt)

(HBV) () -- - HBV--FL

FRT, 50F, -

B (HBV) (- ), - , , / , QIAsymphony, NucliSENS easy- MAG, XIRIL. RG, iQ, , Mx, CFX.

15

80 IVD

R-V5-G-F

- A, B, C D - B (HBV) - - () -- - HBV--FL

FRT, 50F, -

- A, B, C D B (HBV). HBV - (.104-20). 4- RG, iQ, ,CFX

15

55 IVD

V5-FEP

B (HBV) - () - - HBV-FL

FEP, 100F, -

B (HBV) HBV -, - -.

8 110 IVD

V5-100-R0,5

B (HBV) - () - HBV-EPh

EPh, 100R, - 0,5, -

B (HBV). HBV -, - -

8 110 IVD

V5-100-R0,2

EPh, 100R, - 0,2, -

8 110 IVD

-

.

.

-

-

TM-V5-F-1 HBV-Resist-Seq

EPh, 50F

(RT) - (HBV) - /. - Applied Biosystems. Applied Biosystems.

15

55 RUO

RUO-

20

M-V5-F-2 HBV-Resist-Seq

EPh, 50F

(RT) - (HBV) - / . - Applied Biosystems.. - - Applied Biosystems

15

55 RUO

-

.

.

-

-

R-V1-Mod (RG,iQ,Mx,Dt)

C (HCV) - - - () --- HCV-FL

FRT, 100F, -

- (HV). HV -, - -. RG, iQ, , Mx ,CFX

112 IVD

R-V1-G-4x(RG,iQ,Mx)

- (1, 2, 3) C (HCV) () -- - -HCV-1/2/3-FL

FRT, 50F, -

- ( ( 1, 2, 3) - ). HCV --, - -. 4- RG, iQ, , Mx, CFX.

55 IVD

R-V1-G(1-4)-2 (RG,iQ,Mx,Dt,SC)

- C (HCV) () -- - HCV--FL

FRT, 50F, -

1a, 1b, 2, 3, 4 C () - HCV - , , . RG, iQ, , Mx ,SC,CFX

15

165(55) IVD

R-V1-G(1-6)-2 (RG,iQ,Mx,Dt,SC)

- C (HCV) () -- - HCV--FL

FRT, 50F, -

1a, 1b, 2, 3, 4, 5, 6 - C (). - HCV , , - . RG, iQ, , Mx, SC, CFX.

15

220(55) IVD

RUO-

21

TR-V1-P-M(RG,iQ,,Dt)

- C (HCV) - - - () -- - HCV--FL

FRT, 50F,

(HV). -. RG, iQ, , Mx, CFX.

15

50 IVD

TR-V1-S-MC (RG,iQ,Mx,Dt)

FRT, 48F,

C (HCV) , --12. - RG, iQ, , Mx, CFX.

48 IVD

TR-V1-M-MC (RG,iQ,Mx,Dt)

- C (HCV) - () - - - HCV--FL

FRT, 100F,

C (HCV) - 100-1000. RG, iQ, , Mx, CFX.

15

100 IVD

R-V1-MC (RG,iQ,,Dt)

FRT, 50F, -

- (HCV) ( -), , - , - / , QIAsymphony, NucliSENS easy-MAG, XIRIL. RG, iQ, , Mx,CFX

15

80 IVD

V1-FEP

C (HCV) - () - - HCV-FL

FEP, 100F,-

- (HV). HCV -, - -

112 IVD

V1-G-FEP

- (1, 2, 3) C (HCV) () -- - HCV-1/2/3-FL

FEP, 50F, -

- ( ( 1, 2, 3) ). 3- . HCV -, - -.

15

55 IVD

V1-100-R0,5

P C (HCV) - () - HCV-EPh

EPh, 100R, 0,5, -

(HCV) ( ) - -L (. 3-4-100). () .

110 IVD

V1-100-R0,2

EPh, 100R, 0,2, -

8 110 IVD

RUO-

22

V1-G50-R0,5

- (1a, 1b, 2, 3a) C (HCV) - () - HCV--EPh

EPh, 50R, 0,5, -

( 1a, 1b, 2, 3). ( ) - -L (. 3-4-50). () .

8 55 IVD

V1-G50-R0,2

EPh, 50R, 0,2, -

8 55 IVD

,

-

. .

-

-

R-O5-100-F (RG,iQ,Dt,CX)

- - (SNP) rs8099917 rs12979860 -28B (IL28B) - - () - - -IL28B-FL

FRT, 100F,-

- (SNP) rs8099917 rs12979860 --28B(IL28B) - RG, iQ, Mx, ,CFX

15

110 IVD

D -

.

.

-

-

R-V3 (RG,iQ,Mx,Dt)

D (HDV)

- -

-

() -

--

HDV-FL

FRT,

100F,-

-

(HDV). HV

-, - -.

RG, iQ, , Mx,CFX

15

110 IVD

R-V3-MC (RG,iQ,,Dt)

HDV-M-FL

FRT,

50F, -

-

D (HDV)( -

),

, -

, -

/

,

QIAsymphony, Xiril, NucliSENS easy- MAG. RG, iQ, , Mx,CFX.

15

80 RUO

RUO-

23

V3-FEP

D (HDV)

-

-

-

() -

- -

HDV-FL

FEP,

100F, -

-

(HDV). HV

-

-, - -

15

110 IVD

G -

.

.

-

-

R-V2-50-F (RG,iQ,Mx,Dt)

G (HGV) - - - () -- HGV-FL

FRT, 50F, -

- G (HGV). RG, iQ, , Mx, CFX.

15

55 IVD

V2-50F-FEP FEP, 50F, -

- G (HGV).

15

55 IVD

-- XIRIL

-. -. . . - .

-

. .

-

-

R-B60(RG)

- Chlamydia trachomatis, Ureaplasma ( Parvum Urealyticum), Mycoplasma genitalium Mycoplasmahominis -- - , -

C.trachomatis/ Ureaplasma /M.genitalium/ M.hominis--FL

FRT, 100R,-

Chlamydia trachomatis/ Ureaplasma (Parvum Urealyticum)/ Mycoplasma genitalium / Mycoplasma hominis . 5- RG, CFX,

110 IVD

R-B60-F(RG) FRT, 100F,-

Chlamydia trachomatis/ Ureaplasma (Parvum Urealyticum)/ Mycoplasma genitalium / Mycoplasma hominis . 5- RG, CFX,

110 IVD

RUO-

24

R-B81(RG)

- - Ureaplasma parvum, Ureaplasma urealyticum Mycoplasma hominis () -- U.parvum /U.urealyticum/ M.hominis---FL

FRT, 100R,-

( - ) Ureaplasma parvum, Ureaplasma urealyticum Mycoplasma hominis. RG, CFX.

15

110 IVD

R-B83 T.vaginalis/ N.gonorrhoeae/ C. trachomatis--FL

FRT, 100R,-

- Trichomnas vaginalis, Neisseria gonorrhoeae Chlamydia trachomatis . - RG, iQ, Mx, CFX.

15

110 RUO

R-B83-F (RG,iQ)

FRT, 100F,-

15

110 RUO

R-B43

- Chlamydia trachomatis, Ureaplasma ( Parvum Urealyticum) Mycoplasma hominis - - - () -- C.trachomatis / Ureaplasma /M.hominis--FL

FRT, 100R,-

C.trachomatis/Ureaplasma/M. hominis trachomatis . RG, iQ, Mx, CFX.

110 IVD

R-B43-F(RG,iQ)

FRT, 100F,-

8 110 IVD

R-B46

- Chlamydia trachomatis, Ureaplasma ( Parvum Urealyticum) Mycoplasma genitalium - - - () -- - C.trachomatis / Ureaplas-ma/M.genitalium--FL

FRT, 100R,-

C.trachomatis/Ureaplasma/M. genitalium . RG, iQ, Mx, CFX.

110 IVD

R-B46-F(RG,iQ)

FRT, 100F,-

8 110 IVD

R-B67 N.gonorrhoeae/ C.trachomatis/ M.genitalium--FL

FRT, 100R,-- -

Neisseria gonorrhoeae, Chlamydia trachomatis Mycoplasma genitalium . - RG, iQ, Mx, CFX.

15

110 RUO

R-B67-F(RG,iQ)

FRT, 100F,-

15

110 RUO

RUO-

25

R-F3

- Candida albicans, Candida glabrata Candida krusei () -- - - Candida albicans, Candida glabrata Candida krusei - - - () --- C.albicans /C.glabrata / C.krusei -FL

FRT, 100R,-

Candida: C.albicans, C.crusei, C.glabrata ( ) . RG, iQ, , Mx CFX.

110 IVD

R-F3-F(RG,iQ)

FRT, 100F,-

8 110 IVD

R-B87 HSV II/ HSV I/ T. pallidum--FL

FRT, 100R, 0,2 - -

HSV II, HSV I Treponema pallidum. RG, iQ, Mx, CFX.

15

110 RUO

R-B87-F (RG,iQ,Dt, MX,CFX)

FRT, 100F,-

15

110 RUO

R-B65

- Trichomonas vaginalis Neisseria gonorrhoeae - - - () --- T.vaginalis/N. gonorrhoeae- -FL

FRT, 100R,--

- Trichomnas vaginalis Neisseria gonorrhoeae . RG, iQ, Mx, CFX.

110 IVD

R-B65-F(RG,iQ)

FRT, 100F,-

15

110 IVD

R-B7-FT (RG,iQ,Mx)

Gardnerella vaginalis / Lactobacillus species--FL

FRT, 100F,-

G.vaginalis Lactobacillus spp. (- )- - . RG, iQ, Mx CFX.

15

110 RUO

B83-100-R0,5- FEP

T.vaginalis/ N.gonorrhoeae/C. trachomatis- --FL

FEP, 100R, 0,5, -

- Trichomnas vaginalis, Neisseria gonorrhoeae Chlamydia trachomatis . 3- -.

15

110 RUO

B83-100-R0,2- FEP

FEP, 100R, 0,2, -

15

110 RUO

RUO-

26

B43-100-R0,2- FEP

- Chlamydia trachomatis, Ureaplasma ( Parvum Urealyticum) Mycoplasma hominis - - - () -- - C.trachomatis / Ureaplasma /M.hominis--FL

FEP, 100R, 0,2, -

Chlamydia trachomatis/ Ureaplasma (parvum urealyticum) / Mycoplasma hominis. 4- .

8 110 IVD

B43-100-R0,5- FEP

FEP, 100R, 0,5, -

8 110 IVD

B46-100-R0,2- FEP

- Chlamydia trachomatis, Ureaplasma ( Parvum Urealyticum) Mycoplasma genitalium () - - C.trachomatis / Ureaplasma/ M.genitalium--FL

FEP, 100R, 0,2, -

Chlamydia trachomatis, Ureaplasma ( Parvum Urealyticum) Mycoplasma genitalium. 4- .

8 110 IVD

B46-100-R0,5- FEP

FEP, 100R, 0,5, -

110 IVD

B67-100-R0,2- FEP

N.gonorrhoeae/ C. trachomatis/ M.genitalium--FL

FEP, 100R, 0,2, -

Neisseria gonorrhoeae, Chlamydia trachomatis Mycoplasma genitalium. 4- .

15

110 RUO

B67-100-R0,5- FEP

FEP, 100R, 0,5, -

Neisseria gonorrhoeae, Chlamydia trachomatis Mycoplasma genitalium. 4- .

15

110 RUO

B65-100-R0,5- FEP

- Trichomonas vaginalis Neisseria gonorrhoeae - - - () -- T.vaginalis/N. gonorrhoeae--FL

FEP, 100R, 0,5 -

- Trichomonas vaginalis Neisseria gonorrhoeae. 3- .

15

110 IVD

B65-100-R0,2- FEP

FEP, 100R, 0,2 -

- Trichomonas vaginalis Neisseria gonorrhoeae. 3- .

15

110 IVD

B66-100-R0,2- FEP

C.trachomatis/ M. genitalium- -FL

FEP, 100R, 0,2, -

Chlamydia trachomatis Mycoplasma genitalium. 3- .

15

110 RUO

B66-100-R0,5- FEP

FEP, 100R, 0,5, -

Chlamydia trachomatis Mycoplasma genitalium. 3- .

15

110 RUO

RUO-

27

B47-100-R0,5- FEP

C.trachomatis/ Ureaplasma- -FL

FEP, 100R, 0,5, -

C.trachomatis / Ureaplasma. 3- .

8 110 RUO

B47-100-R0,2- FEP

FEP, 100R, 0,2, -

C.trachomatis / Ureaplasma. 3- .

8 110 RUO

B48-100-R0,5- FEP

Mycoplasma hominis / Gardnerella vaginalis- -FL

FEP, 100R, 0,5, -

Mycoplasma hominis / Gardnerella vaginalis. 3- .

8 110 RUO

B48-100-R0,2- FEP

FEP, 100R, 0,2, -

Mycoplasma hominis / Gardnerella vaginalis. 3- .

8 110 RUO

-

.

.

-

-

R-B61(RG)

- Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium Trichomonas vaginalis -- , - N.gonorrhoeae/ C.trachomatis / M.genitalium/ T.vaginalis--FL

FRT, 100R, 0,2 -

Neisseria gonorrhoeae/Chlamydia trachomatis/ Mycoplasma genitalium / Trichomonas vaginalis . 5- RG, CFX, .

110 IVD

R-B61-F(RG) FRT, 100F,-

8 110 IVD

R-B75-100-FT (RG,iQ,Mx)

- - U.parvum, U.urealyticum M.hominis - - () -- / -FL

FRT, 100F,-

Ureaplasma parvum, Ureaplasma urealyticum Mycoplasma hominis RG, iQ, Mx, CFX.

110 IVD

R-F5-100- FT(RG,CFX)

- - Candida (C.albicans, C.glabrata, C.krusei, C.parapsilosis C.tropicalis) - - () - - / -FL

FRT, 100F,-

- Candida (C.albicans, C.glabrata, C.krusei, C.parapsilosis C.tropicalis) . RG, CFX.

110 IVD

RUO-

28

R-B74-100- FT(RG)

- ( - Gardnerella vaginalis, Atopobium vaginae, Lactobacillus spp. - ) - - () -- / -FL

FRT, 100F,-

Gardnerella vaginalis, Atopobium vaginae, Lactobacillus spp. . . RG, iQ, CFX.

110 IVD

R-B88-100-FT

/ -FL

FRT, 100F,-

- - ( Enterobacteriaceae, E.coli, Klebsiella spp, Proteus spp .), - (Staphylococcus spp) - (Streptococcus spp). 4- RG, iQ, CFX

15

110 RUO

Chlamydia trachomatis -

.

.

-

-

R-B1-100-FT (RG,iQ,Mx)

C.trachomatis- --FL

FRT, 100F,-

Chlamydia trachomatis ( ).

RG, iQ, Mx CFX.

15 c

110 RUO

R-B1

Chlamydia trachomatis - - - () -- -

Chlamydia trachomatis-FL

FRT, 100R, 0,2,-

Chlamydia trachomatis. RG, iQ, Mx, CFX.

110 IVD

R-B1-F(RG,iQ)

FRT, 100F,-

8 c 110 IVD

B1-100-R0,5- FEP

FEP, 100R, 0,5,-

Chlamydia trachomatis.

110 IVD

B1-100-R0,2- FEP

FEP, 100R, 0,2,-

110 IVD

B1-100-R0,5

Chlamydia trachomatis - - - () - - - - Chlamydia trachomatis-EPh

EPh, 100R, 0,5,-

Chlamydia trachomatis.

110 IVD

B1-100-R0,2

EPh, 100R, 0,2,-

110 IVD

RUO-

29

Neisseria gonorrhoeae -

.

.

-

-

R-B51

Neisseria gonorrhoeae - - - Neisseria gonorrhoeae --FL

FRT, 100R, -

N.gonorrhoeae ( !). RG, iQ, Mx, CFX.

8 110 IVD

R-B51-F(RG,iQ)

FRT, 100F,-

8 110 IVD

R-B56

Neisseria gonorrhoeae - - -. Neisseria gonorrhoeae--FL

FRT,100R,--

Neisseria gonorrhoeae ( !). N. gonorrhoeae - , -. RG, iQ, Mx, CFX.

8 110 IVD

R-B56-F(RG,iQ)

FRT, 100F,-

8 110 IVD

B51-100-R0,5- FEP

Neisseria gonorrhoeae - - - Neisseria gonorrhoeae-c-FL

FEP, 100R, 0,5,-

N.gonorrhoeae ( !)

8 110 IVD

B51-100-R0,2- FEP

FEP, 100R, 0,2,-

8 110 IVD

B56-100-R0,2- FEP

Neisseria gonorrhoeae - () -- - Neisseria gonorrhoeae--FL

FEP, 100R, 0,2,-

N.gonorrhoeae ( -!). - N. gonorrhoeae - , -

8 110 IVD

B56-100-R0,5- FEP

FEP, 100R, 0,5,-

N.gonorrhoeae ( -!). - N. gonorrhoeae - , -

8 110 IVD

B5-100-R0,5

Neisseria gonorrhoeae - () - - - Neisseria gonorrhoeae-EPh

EPh, 100R, 0,5,-

N.gonorrhoeae( 2 -: 80 , 30 - - )

-

110 IVD

B5-100-R0,2

EPh, 100R, 0,2,-

N.gonorrhoeae( 2 -: 80 , 30 - - ).

8 110 IVD

RUO-

30

Treponema pallidum -

.

.

-

-

R-B20 Treponema pallidum () - - Treponema pallidum-FL

FRT, 100R,-

T.pallidum. RG, iQ, Mx, CFX.

8 110 IVD

R-B20-F(RG,iQ)

FRT, 100F,-

8 110 IVD

B20-100-R0,5- FEP

FEP, 100R, 0,5,

T.pallidum.

-

110 IVD

B20-100-R0,2- FEP

FEP, 100R, 0,2,

T.pallidum.

8 110 IVD

B20-100-R0,5

Treponema pallidum - () -

Treponema pallidum-EPh

EPh, 100R, 0,5,-

T.pallidum.

8 110 IVD

B20-100-R0,2

EPh, 100R, 0,2,-

T.pallidum.

110 IVD

Trichomonas vaginalis -

.

.

-

-

R-B6

Trichomonas vaginalis () - - Trichomonas vaginalis-FL

FRT, 100R,-

T.vaginalis. RG, iQ, Mx, CFX.

-

110 IVD

R-B6-F(RG,iQ) FRT, 100F,-

8 110 IVD

B6-100-R0,5- FEP

FEP, 100R, 0,5,-

T.vaginalis

-

110 IVD

B6-100-R0,2- FEP

FEP, 100R, 0,2,-

T.vaginalis

-

110 IVD

B6-100-R0,5

Trichomonas vaginalis - - - () - - - -

Trichomonas vaginalis-EPh

EPh, 100R, 0,5,-

T.vaginalis

110 IVD

B6-100-R0,2

EPh, 100R, 0,2,-

T.vaginalis

110 IVD

Mycoplasma genitalium -

.

.

-

-

R-B4-100-FT(RG,iQ,Mx)

M.genitalium---FL

FRT, 100F,-

Mycoplasma genitalium ( - ). RG, iQ, Mx CFX.

15

110 RUO

RUO-

31

R-B4 Mycoplasma genitalium - - () -- -

Mycoplasma genitalium-FL

FRT, 100R,-

M.genitallium. RG, iQ, Mx, CFX.

110 IVD

R-B4-F(RG,iQ)

FRT, 100F,-

8 110 IVD

B4-100-R0,5- FEP

FEP, 100R, 0,5,-

M.genitallium

110 IVD

B4-100-R0,2- FEP

FEP, 100R, 0,2,-

M.genitallium

110 IVD

B4-100-R0,5

Mycoplasma genitalium - - - () - - - -

Mycoplasma genitalium-EPh

EPh, 100R, 0,5,-

M.genitallium

110 IVD

B4-100-R0,2

EPh, 100R, 0,2,-

M.genitallium

110 IVD

Mycoplasma hominis -

.

.

-

-


- - M.hominis - - - () --- M. hominis---FL

FRT, 100F,-

Mycoplasma hominis ( - ). - RG, iQ, Mx CFX.

15

110 IVD

R-B3 - - M.hominis - - - () --- Mycoplasma hominis-FL

FRT, 100R,-

M.hominis. RG, iQ, Mx, CFX.

110 IVD

R-B3-F(RG,iQ)

FRT, 100F,-

8 110 IVD

B3-100-R0,5- FEP

FEP, 100R, 0,5,--

M.hominis

110 IVD

B3-100-R0,2- FEP

FEP, 100R, 0,2, -

M.hominis

110 IVD

B3-100-R0,5

Mycoplasma hominis - - - () - - - - Myco-plasma hominis-EPh

EPh, 100R, 0,5 -

M.hominis

110 IVD

B3-100-R0,2

EPh, 100R, 0,2 -

M.hominis

110 IVD

RUO-

32

Ureaplasma species -

.

.

-

-


- - Ureaplasma spp. () -- - Ureaplasma spp.---FL

FRT, 100F,-

Ureaplasma parvum Ureaplasma urealyticum () ( - ). - RG, iQ, Mx CFX.

15

110 IVD

R-B2

- Ureaplasm (Ureaplasma spp.) - - - () --- Ureaplasma spp.-FL

FRT, 100R,-

Ureaplasma parvum Ureaplasma urealyticum (). RG, iQ, Mx, CFX.

110 IVD

R-B2-F(RG,iQ)

FRT, 100F,-

8 110 IVD

B2-100-R0,5- FEP

- Ureaplasm (Ureaplasma spp.) - - - () --- Ureaplasma spp.-FL

FEP, 100R, 0,5, -

Ureaplasma parvum Ureaplasma urealyticum ()

110 IVD

B2-100-R0,2- FEP

FEP, 100R, 0,2,-

Ureaplasma parvum Ureaplasma urealyticum ().

110 IVD

B2-100-R0,5

- Ureaplasma (U.parvum U.urealyticum) - - () - -

Ureaplasma spp.-EPh

EPh, 100R, 0,5,-


110 IVD

B2-100-R0,2

EPh, 100R, 0,2,-


110 IVD

Ureaplasma -

.

.

-

-

R-B19-100- FT(RG,iQ,Mx)

U.parvum/ U.urealyticum- --FL

FRT, 100F,-

Ureaplasma parvum Ureaplasma urealyticum ( - ). RG, iQ, Mx CFX.

15

110 RUO

RUO-

33

R-B19 - U.parvum U.urealyticum - - () -- U.parvum/ U.urealyticum-FL

FRT, 100R,-

. - Ureaplasma parvum Ureaplasma urealyticum. RG, iQ, Mx, CFX.

8 110 IVD

R-B19-F(RG,iQ)

FRT, 100F,-

8 110 IVD

B19-100-R0,5- FEP

FEP, 100R, 0,5, -

. - Ureaplasma parvum Ureaplasma urealyticum.

110 IVD

B19-100-R0,2- FEP

FEP, 100R, 0,2, -


110 IVD

B19-100-R0,5

U. parvum/ U.urealyticum-EPh

EPh, 100R, 0,5, -


8 110 RUO

B19-100-R0,2

EPh, 100R, 0,2, -


8 110 RUO

Gardnerella vaginalis . G.vaginalis Lactobacillus spp,

-

. .

-

-

R-B7 Gardnerella vaginalis - - - () -- - Gardnerella vaginalis-FL

FRT, 100R,-

G.vaginalis. RG, iQ, Mx, CFX.

110 IVD

R-B7-F(RG,iQ)

FRT, 100F,-

8 110 IVD

B7-100-R0,5- FEP

FEP, 100R, 0,5,--

G.vaginalis

110 IVD

B7-100-R0,2- FEP

FEP, 100R, 0,2,--

G.vaginalis

110 IVD

B7-100-R0,5

Gardnerella vaginalis - () - - Gardnerella vaginalis-EPh

EPh, 100R, 0,5,--

G.vaginalis

110 IVD

B7-100-R0,2

EPh, 100R, 0,2,--

G.vaginalis

110 IVD

Candida albicans -

.

.

-

-

R-F1 Candida albicans () -- - Candida albicans-FL

FRT, 100R,-

C.albicans. RG, iQ, Mx, CFX

110 IVD

R-F1-F(RG,iQ)

FRT, 100F,-

8 110 IVD

F1-100-R0,5- FEP

FEP, 100R, 0,5,-

C.albicans

110 IVD

F1-100-R0,2- FEP

FEP, 100R, 0,2,-

C.albicans

110 IVD

RUO-

34

F1-100-R0,5

H Candida albicans () - - - Candida albicans-EPh

EPh, 100R, 0,5,-

C.albicans

110 IVD

F1-100-R0,2

EPh, 100R, 0,2,-

C.albicans

110 IVD

NASBA-Real-Time - NASBA-Real-Time (Nucleic Acid Sequenced- Based Amllifica-tion), BioMerieux (). . NASBA . NASBA-Real-Time - . .

-

. .

-

-

TN-B1

Chlamydia trachomatis, - , NASBA - - Chlamydia trachomatis-

NASBA

Chlamydia trachomatis . RG, iQ

15

60 IVD

TN-B5

Neisseria gonorrhoeae NASBA - - Neisseria gonorrhoeae-

NASBA

Neisseria gonorrhoea . RG, iQ

15

60 IVD

TN-B4

Mycoplasma genitalium - NASBA Mycoplasma genitalium

NASBA

Mycoplasma genitalium . RG, iQ

15

60 IVD

TN-B6

Trichomonas vaginalis - NASBA Trichomonas vaginalis

NASBA

Trichomonas vaginalis . RG, iQ

15

60 IVD

-

. .

-

-

R-V67-F

--FL

FRT, 100 F,-

, - () - 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 68. 4- RG, iQ, Mx, CFX .

15

110 RUO

RUO-

35

R-V31-F - - - () - () 16, 18, 31, 33, 35,39, 45, 51, 52, 56, 58, 59 - () -- - --FL

FRT, 100F,-

- 16, 18, 31, 33, 35,39, 45, 51, 52, 56, 58, 59, 66 68() 16, 18 45 ( ). 5- RG, CFX.

15

110 RUO

R-V31-T-4x (RG,iQ,Mx)

FRT, 4x, 100F,-

(- -) ( 16,18,31,33,3 5,39,45,51,52,56,58,59 ). 4- RG, iQ,Mx

108 IVD

R-V31-T-2x(RG,iQ,SC)

FRT, 2x, 100F,-

(- -) ( 16,18,31,33,3 5,39,45,51,52,56,58,59 ). 2- RG, iQ,SC

15

108 IVD

R-V25 (RG,iQ,Mx)

- - - () () 16, 18, 31,33, 35, 39, 45, 51, 52, 56, 58, 59 () -- - -FL

FRT, 100F,-

(- 16, 18, 31, 33, 35, 39, 45, 51, 52,56, 58, 59 ). 4- RG, iQ,Mx, CFX

108 IVD

R-V12-F - - - () 16 18 () -- - 16/18-FL

FRT,100F, -

(-, - ) () 16 18 . : - -- .102-22, -- . 103-20, -- -. 4- RG,iQ,Mx,CFX,Dt

110 IVD

R-V12-100 FRT,100R,-

(-, - ) () 16 18 . : - - -- .102-22, -- . 103-20, -- -. 4- RG,iQ,Mx,CFX,Dt

15

110 IVD

RUO-

36

V12-FEP-F

- - - () 16 18 () -- - 16/18-FL

FEP, 100F, -

() 16 18 .

110 IVD

V12-100-R0,5- FEP

FEP,100R, -

15

110 IVD

V12-100-R0,2- FEP

FEP,100R, -

15

110 IVD

V31-FEP

- - () () 16, 18, 31, 33, 35, 39, 45, 52, 58,59, 67 () c -- - -FL

FEP, 100F,-

( 16, 18, 31, 33, 35, 39, 45, 52, 58, 59, 67 , 16 ). 2- .

120 IVD

V31-3x-FEP FEP, 100F,-

( 16, 18, 31, 33, 35, 39, 45, 52, 58, 59, 67 ). 3- -.

120 IVD

V31-100F

- - () () 16, 18, 31, 33, 35, 39, 45, 52,53, 56, 58, 59, 66, 70 - - () - -EPh

EPh, 100F,-

( ) 16, 18, 31, 33, 35, 39, 45,52, 53, 56, 58, 59, 66, 70 .

110 IVD

V12-100-R0,5

- - - () 16 18 () - - - 16/18-EPh

EPh, 100R, 0,5,--

16 18

110 IVD

V12-100-R0,2

EPh, 100R, 0,2, -

16 18

110 IVD

V13-100-R0,5

31/-EPh

EPh, 100R, 0,5,-

31 33

8 110 RUO

V13-100-R0,2

EPh, 100R, 0,2,-

31 33

8 110 RUO

RUO-

37

V14-100-R0,5

35/45-EPh

EPh, 100R, 0,5,-

35 45

8 110 RUO

V14-100-R0,2

35/45-EPh

EPh, 100R, 0,2, -

35 45

110 RUO

V25-50F

- - - () () 16, 31, 33,35; 18, 39, 45, 59 52, 56,58, 66 - - () - -EPh

EPh, 50F, -

- ( ) 16,18,31,33,35,39,45,52,56, 58,59,66

55 IVD

-

.

.

-

-

R-V11-Mod (RG,iQ,Mx)

- - - () 6 11 - () -- - 6/11-FL

FRT, 100F,-

6 11 . RG, iQ, Mx, ,CFX.

110 IVD

R-V11-100 - - - () 6 11 - () -- - 6/11-FL

FRT,100R, -

() 6 11 . - : - -- .102-22, -- . 103-20, -- -. RG, iQ, Mx, ,CFX

15

110 IVD

V11- Mod-FEP

FEP, 100F,-

() 6 11 . - : - -- .102-22, -- . 103-20, -- -.

110 IVD

V11-100-R0,5- FEP

FEP,100R, -

15

110 IVD

V11-100-R0,2- FEP

FEP,100R, -

15

110 IVD

RUO-

38

V11-100-R0,5

6/11-EPh

EPh, 100R, 0,5,-

6 11

8 110 RUO

V11-100-R0,2

EPh, 100R, 0,2,-

6 11

8 110 RUO

-

-. - -. . . .

-

. .

-

-

R-V60 HSV/CMV--FL

FRT, 100R,-

(HSV) - (CMV). RG, iQ, Mx,.

15

110 RUO

R-V60-F(RG,iQ)

FRT, 100F,-

15

110 RUO

R-V48- S(RG,iQ,Mx)

- - - (EBV), (CMV) - 6 (HHV6) - - - -- EBV/ CMV/ HHV6-c-FL

FRT, 100F,-

( -) -, - 6 . 4- RG, iQ, Mx, , CFX

110 IVD

V60-100-R0,5- FEP

HSV/CMV--FL

FEP, 50R, 0,5,-

(HSV) - (CMV).

15

110 RUO

V60-100-R0,2- FEP

FEP, 50R, 0,2,-

15

110 RUO

-

.

.

-

-

R-V7

- (CMV) - - () - CMV-FL

FRT, 100R,- CMV. -

CMV - -- (. 103-20) -FL (. 133). RG, iQ, Mx,, CFX

110 IVD

R-V7-F(RG,iQ)

FRT, 100F,-

8 110 IVD

RUO-

39

R-V7-100-S(RG,iQ,Mx)

- (CMV) - () - - CMV-/-FL

FRT, 100F,-

(CMV) ( ). , , , , , . RG, iQ, Mx.

110 IVD

V7-100-R0,5- FEP

- (CMV) - - () - - CMV-FL

FEP, 100R, 0,5, -

CMV. CMV - -- (. 103-20) -FL (. 133)

110 IVD

V7-100-R0,2- FEP

FEP, 100R, 0,2, -

110 IVD

V7-100-R0,5

- (CMV) () - - - CMV- EPh

EPh, 100R, 0,5,-

CMV

110 IVD

V7-100-R0,2

EPh, 100R, 0,2,-

CMV

110 IVD

- -

.

.

-

-

R-V9-100-S(RG,iQ,Mx)

- - (EBV) - - () - - EBV-/ -FL

FRT, 100F,-

- (EBV) ( - ). , , , , , . RG, iQ, Mx, CFX

110 IVD

V9-100-R0,5

EBV-EPh

EPh, 100R, 0,5,-

- (EBV).

8 110 RUO

V9-100-R0,2

EPh, 100R, 0,2,-

8 110 RUO

RUO-

40

Varicella-Zoster virus -

.

.

-

-

R-V61-50-F(RG)

Varicella-Zoster virus (VZV) () - - VZV-FL

FRT, 50F, --

Varicella-Zoster virus (VZV). RG.

15

60 IVD

6- -

.

.

-

-

R-V10- T(RG,iQ,Mx)

- - - 6 (HHV6) - - - () - - HHV6 -- -FL

FRT, 100F,-

6 ( - ). - . - , , . - RG, iQ, Mx, CFX

15

110 IVD

V10-100-R0,5

HHV VI Eph

EPh, 100R, 0,5,-

6 .

8 110 RUO

V10-100-R0,2

EPh, 100R, 0,2,-

8 110 RUO

1 2 -

.

.

-

-

R-V8 I II (HSV I, II) - - () --- HSV I, II-FL

FRT, 100R,-

(HSV) 1 2 -. HSV - -- (. 103-20) -FL (. 133). RG, iQ, Mx,

110 IVD

R-V8-F(RG,iQ)

FRT, 100F,-

110 IVD

V8-100-R0,5- FEP

FEP, 100R, 0,5,-

(HSV) 1 2 -. HSV - -- (. 103-20) -FL (. 133)

110 IVD

V8-100-R0,2- FEP

FEP, 100R, 0,2,-

110 IVD

V8-100-R0,5

I II (HSV I, II) - - () - - - - HSV I, II-EPh

EPh, 100R, 0,5,-

(HSV) 1 2

110 IVD

V8-100-R0,2

EPh, 100R, 0,2,-

110 IVD

RUO-

41

-

.

.

-

-

R-V38

HSV-typing-FL

FRT, 100R,-

(- 1 2 ). HSVI HSVII - -- (. 103-20) -FL (. 133). 4- RG, iQ, Mx, .

8 110 RUO

R-V38-F(RG,iQ)

FRT, 100F,-

8 110 RUO

V38-100-R0,5- FEP

HSV-typing-FL

FEP, 100R, 0,5,--

(- 1 2 ). HSVI HSVII - -- (. 103-20) -FL (. 133). 3- -.

8 110 RUO

V38-100-R0,2- FEP

FEP, 100R, 0,2, -

8 110 RUO

- -

.

.

-

-

R-B76-50-FT(RG,iQ)

- Pseudomonas aeruginosa - - () - - Pseudomonas aeruginosa---FL

FRT, 50F, -

Pseudomonas aeruginosa. RG, iQ.

15

60 IVD

R-B77-100- FT(RG,iQ)

- Streptococcus agalactiae () -- - Streptococcus agalactiae-- FL

FRT, 100F,-

Streptococcus agalactiae. RG, iQ.

15

110 IVD


Streptococcus pyogenes---FL

FRT, 100F,-

Streptococcus pyogenes. RG, iQ.

15

110 RUO

RUO-

42


- - - - Staphylococcus aureus, - - Staphylococcus spp. - - () -- - MRSA---FL

FRT, 100F,-

Staphylococcus aureus. RG, iQ.

15

110 IVD

MDR -

.

.

-

-

R-C1 (RG,CFX)

--b- VIM, IMP NDM - () -- MDR MBL-FL

FRT, 100F,-

( - -- () VIM, IMP NDM). RG, CFX.

15

110 IVD

R-C2 (RG,CFX)

- KPC OXA-48 - - () - MDR KPC/OXA-48-FL

FRT, 100F,-

( - KPC OXA-48- (- OXA-48 OXA-162)). RG, CFX.

15

110 IVD

TORCH- 1 2 . . 6 . - . Streptococcus . -

Toxoplasma gondii -

.

.

-

-

R-P1 (RG,iQ,Mx)

Toxoplasma gondii - - - - () - - -

Toxoplasma gondii-FL

FRT, 50F, -

Toxoplasma gondii (: 400 / 4 / Toxoplasma gondii). RG, iQ, Mx.

60 IVD

RUO-

43

19 -

.

.

-

-

R-V49 (RG,iQ,Mx)

- Parvovirus B19 () - -

Parvovirus B19-FL

FRT, 50F, -

Parvovirus B19. RG, iQ, Mx

15

55 IVD

-

.

.

-

-

R-V24- S(RG,iQ,Mx)

(Rubella virus) () - - Rubella virus-FL

FRT, 50F, -

. RG, iQ, Mx

15

60 IVD

. , QIAGEN

-

. .

-

-

IRGA-

0594-0201

in-vitro QuantiFERON-TB Gold ELISA

- INF-.

- INF- -

2 96 RUO

IRGA-

0590-0301

- Gold (QuantiFERON-TB Gold Blood Collection Tubes) TB Antigen

Tube, Nil Tube, Mitogen Tube

, - . (TB Antigen Tube), (Nil Tube), - (Mitogen Tube)

100 RUO

IRGA-

0597-0201

QuantiFERON - TB Gold Single Patient Pack

, - . (TB Antigen Tube), (Nil Tube), - (Mitogen Tube)

10 RUO

IRGA-

0590-0201

- Gold - (QuantiRERON- TB Gold Antigens)

TB Antigen Tube, Nil Tube

, - . (TB Antigen Tube), (Nil Tube)

100 RUO

IRGA-

T0593-0201

- Gold (Quan- tiRERON-TB Gold Mitogen tubes)

Mitogen Tube

, - . (Mitogen Tube)

100 RUO

IRGA-

0594-0805

- in-vitro QuantiFERON Control Panel

- . - (IFN-) .

- RUO

RUO-

44

-

.

.

-

-

R-B80 (RG,iQ,Dt,SC)

- (M.tuberculosis, M.bovis M.bovis BCG) - - () -- - MTC-diff-FL

FRT, 50F, --

- (M. tuberculosis, M. bovis M. bovis BCG). RG, iQ, SC, , CFX

15

55 IVD

Mycobacterium tuberculosis complex -

.

.

-

-

R-B57 (RG,iQ, SC,Dt96)

- (Mycobacterium tuberculosis complex) , - () - - MTC-FL

FRT,50F,-

Mycobacterium tuberculosis complex (M. tuberculosis, M. bovis, M. bovis BCG, M. africanum, M. microti, M. canetti, . pinipedii). RG, iQ, SC, Mx, , CFX

15

55 IVD

B57-FEP FEP, 50F, -

Mycobacterium tuberculosis complex (M. tuberculosis, M. bovis, M. bovis BCG, M. africanum, M. microti, M. canetti, . pinipedii)

15

55 IVD

B15-100-R0,5

Mycobacterium tuberculosis complex () - -EPh

EPh, 100R, 0,5,-

Mycobacterium tuberculosis complex (M. tuberculosis, M.bovis, M.bovis BCG, M.africanum, M.microti). - () .

8 110 IVD

B15-100-R0,2

EPh, 100R, 0,2,-

110 IVD

-

.

.

-

-

B57-1-50F-D MTC-Rif-Seq

EPh, 50F, -

( - (Mycobacterium tuberculosis complex) ) . -. - .*

55 RUO

RUO-

45

B57-2-50F-D MTC-Rif-Seq

EPh, 50F, -

( (Mycobacterium tuberculosis complex) . -. - .*

55 RUO

B57-3-50F-D MTC-PZA-Seq

EPh, 50F, --

(- pncA, (Mycobacterium tuberculosis complex) . -. - .*

55 RUO

B57-4-50F-D MTC-PZA-Seq

EPh, 50F, --

pncA, - (Mycobacterium tuberculosis complex) - - . -. .*

55 RUO

* . -

-

. .

-

-

R-V57

- - - () -- (human Respiratory Syncytial virus - hRSv), - (human Metapneumovirus-hMpv), - 1, 2, 3 4 (human Parainfluenza virus-1-4-hPiv), - (human CoronavirushCov), - (human Rhinoviru -hRv), - B, C E(human Adenovirus B,C,E- hAdv) (human BocavirushBov) - -- - --FL

FRT, 50R, 0,2, -

: - (human respiratory syncytial virus hRSv), (human metapneumovirus hMpv), - 1, 2, 3 4 (human Parainfluenza virus-1-4 hPiv), - (human coronavirus hCov), - (human rhinovirus hRv), - B, C E (human adenovirus B, C, E hAdv) (human bocavirus hBov) (- ()) ( ) -L (. 3-4-50). RG, iQ, ,CFX

15

55 IVD

R-V57-100- F(RG,iQ,Dt)

FRT, 100F,-

15

100 IVD

RUO-

46

R-B84-100- F(RG,iQ,Dt)

- - (Bordetella pertussis), (Bordetellaparapertussis) (Bordetella bronchiseptica) - -- - Bordetella multi-FL

FRT, 100F,-

- (Bordetella pertussis), (Bordetella parapertussis) (Bordetella bronchiseptica) . 4- RG, iQ, ,CFX

15

100 IVD

R-B42-4x-Mod

Mycoplasma pneumoniae Chlamydophila pneumoniae - - () --

Mycoplasma pneumoniae/ Chlamydophila pneumoniae -FL

FRT, 50R, 0,2, -

- Mycoplasma pneumoniae Chlamydophila pneumoniae. 4- - RG,iQ,

55 IVD

B42-50-Mod- R0,5-FEP

FEP, 50R, 0,5, -

M.pneumoniae C.pneumoniae. 3- -

8 55 IVD

B42-50-Mod- R0,2-FEP

FEP, 50R, 0,2, -

8 55 IVD

/ -

.

.

-

-

R-V36-Mod - (Influenza virus A) (Influenza virus ) - - - () -- - Influenza virus A/B-FL

FRT, 50R, 0,2,-

/ (-). ( ) -L (. 3-4-50). 4- RG, iQ, Dt, CFX

15

55 IVD

R-V36-F FRT, 100F,-

15

110 IVD

V36-50-Mod- R0,5-FEP

FEP, 50R, 0,5, -

/ (-). 3- - . ( ) -L (. 3-4-50)

15

55 IVD

V36-50-Mod- R0,2-FEP

FEP, 50R, 0,2, -

15

55 IVD

A/H1 -

.

.

-

-

R-V55

/H1 - () -- Influenza virus /H1-swine-FL

FRT, 50R, 0,2, -

- Influenza virus A/H1. - ( ) - - -L (. 3-4-50). 4- RG, iQ, Dt,,CFX

8 55 IVD

R-V55-F(SC) FRT, 50F, -

55 IVD

RUO-

47

V55-50-R0,5- FEP

/H1 - () -- Influen-za virus /H1-swine-FL

FEP, 50R, 0,5, -

- Influenza virus A/H1 .3- . ( ) -L (. 3-4-50).

55 IVD

V55-50-R0,2- FEP

FEP, 50R, 0,2, -

8 55 IVD

, -

.

.

-

-

R-V66-F

(- H5, H7, H9) (Influenza virus A) - - () -- - Influenza virus A--H5, 7, H9-FL

FRT,50F,-

- H5, H7, H9 (Influenza virus A). - , - Influenza virus A/B-FL Influenza virusA. 3- RG, iQ, CFX.

15

55 IVD

R-V54

(- H1N1 H3N2) (Influenza virus A) - () -- - Influenza virus A--FL

FRT, 50R, 0,2, -

Influenza virus A - H1N1 H3N2. ( ) -L (.3-4-50). 4- RG, iQ, ,CFX

15

55 IVD

V54-50-R0,5- FEP

FEP, 50R, 0,5, -

Influenza virus A - H1N1 H3N2. 3- - ( ) -L (. 3-4-50).

15

55 IVD

V54-50-R0,2- FEP

FEP, 50R, 0,2, -

15

55 IVD

, 5N1 ( ) -

.

.

-

-

R-V33

(Influenza virus A) - H5N1 - - - () - - - Influenza virus A H5N1-FL

FRT, 50R, 0,2, -

H5N1 Influenza virus A. (- ) -L (. 3-4-50). RG,iQ,Dt

55 IVD

V33-50-R0,5- FEP

FEP, 50R, 0,5, -

H5N1 Influenza virus A. (- ) -L (. 3-4-50).

15

55 IVD

V33-50-R0,2- FEP

FEP, 50R, 0,2 -

15

55 IVD

-

.

.

-

-

R-V51 Parainfluenza virus-FL

FRT, 50R, 0,2,-

Parainfluenza virus 1, 2, 3 4 (). - ( ) -L (. 3-4-50). RG iQ,

15

55 RUO

RUO-

48

Mycoplasma pneumoniae -

.

.

-

-

B40-50-R0,5

Mycoplasma pneumoniae-EPh

EPh, 50R, 0,5,-

Mycoplasma pneumoniae.

8 55 RUO

, -

.

.

-

-

R-V65-F

-, - - : MERS-Cov (Middle East respiratory syndrome coronavirus) SARS-Cov (Severe acute respiratory syndrome coronavirus), - - () -- " Cov-Bat-FL"

FRT, 50F, -

- ( ) MERS-CoV (Middle East respiratory syndrome coronavirus) SARS-CoV (Severe acute respiratory syndrome coronavirus). RG, iQ, .

15

55 IVD

- -

.

.

-

-

R-V37

hRSV-FL

FRT, 50R, 0,2,-

- (hRSV). (- ) -L (. 3-4-50). RG, iQ, Dt .

15

55 RUO

V37-50-R0,5- FEP

FEP, 50R, 0,5, -

- (hRSV). (- ) -L (. 3-4-50).

15

55 RUO

V37-50-R0,2- FEP

FEP, 50R, 0,2, -

15

55 RUO

-

.

.

-

-

V23-50-R0,5 Adenovirus-EPh

EPh, 50R, 0,5, -

.

8 55 RUO

V23-50-R0,2

EPh, 50R, 0,2, -

8 55 RUO

Streptococcus species -

.

.

-

-

B18-50-R0,5

Streptococcus spp.-EPh

EPh, 50R, 0,5, -

Streptococcus spp.

8 55 RUO

B18-50-R0,2

EPh, 50R, 0,2 ,-

55 RUO

RUO-

49

Legionella pneumophila -

.

.

-

-

R-B50(RG) Legionella pneumophila - - () -

Legionella pneumophila-FL

- FRT, 50R,-

Legionella pneumophila ( ) (: , , ). RG

15

70 IVD

B50-50-R0,5- FEP

FEP, 50R, 0,5, -

Legionella pneumophila

15

55 IVD

B50-50-R0,2- FEP

FEP, 50R, 0,2, -

15

55 IVD

-

-

. .

-

-

B25(RG,iQ, FEP)

Neisseria meningitidis, Haemophilus influenzae Streptococcus pneumoniae - - () - - N. meningitidis/ H. influenzae/ S. pneumoniae-FL

FRT/ FEP, 50F,-

- Neisseria meningitidis, Haemophilus influenzae Streptococcus pneumonia. RG, iQ ( FRT)

15 55 IVD

V58(RG,iQ ,FEP)

- - (HEV-C) (Sabin1, Sabin2, Sabin3) - - - () -- Poliovirus-FL

FRT/ FEP, 50F,-

(HEV-C) ( Sabin1, Sabin2, Sabin3) . ( ) - -L (. 3-4-50). RG, iQ, Mx ( F

interlabservice catalog osnovnoy 3kv 2015

Documents